CpG island methylation of the MLH1, MGMT, DAPK, and CASP8 genes in cancerous and adjacent noncancerous stomach tissues

Medicina (Lithuania)

Volumn 49, Issue 8, 2013, Pages 361-366

  Kupcinskaite Noreikiene, Rita ^a   Skieceviciene, Jurgita ^a   Jonaitis, Laimas ^a   Ugenskiene, Rasa ^a   Kupcinskas, Juozas ^a   Markelis, Rytis ^a   Baltrenas, Vidmantas ^a   Šakavicius, Linas ^a   Semakina, Irina ^a   Grižas, Saulius ^a   Juozaityte, Elona ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

CASP8; DAPK; Methylation; MGMT; MLH1; Stomach cancer

Indexed keywords

EID: 84897652719     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina49080056     Document Type: Article

References (38)

1. American Cancer Society. Global cancer facts & figures. 2nd ed. Atlanta: American Cancer Society; 2011.
2. Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 2006;12:192-8.
3. Nardone G, Morgner A. Helicobacter pylori and gastric malignancies. Helicobacter 2003;8 (1 Suppl):44-52.
4. Shibata D, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 1992;140:769-74.
5. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006;12:354-62.
6. Chang MS, Uozaki H, Chong JM, Ushiku T, Sakuma K, Ishikawa S, et al. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Clin Cancer Res 2006;12:2995-3002.
7. Kaise M, Yamasaki T, Yonezawa J, Miwa J, Ohta Y, Tajiri H. CpG island hypermethylation of tumor-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk. Helicobacter 2008;13:35-41.
8. Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Hum Pathol 2009;40:1534-42.
9. Ferrasi AC, Pinheiro NA, Rabenhorst SH, Caballero OL, Rodrigues MA, de Carvalho F, et al. Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability. World J Gastroenterol 2010;16:312-9.
10. Kato K, Lida S, Uetake H, Takagi Y, Yamashita T, Inokuchi M, et al. Methylated TMS1 and DAPK genes predict prognosis and response to chemotherapy in gastric cancer. Int J Cancer 2008;122:603-8.
11. Sugita H, Lida S, Inokuchi M, Kato K, Ishiguro M, Ishikawa T, et al. Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer. Oncol Rep 2011;25:513-8.
12. Schneider BG, Peng D, Camargo MC, Piazuelo MB, Sicinschi LA, Mera R, et al. Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Int J Cancer 2010;127:2588-97.
13. Park TJ, Han SU, Cho YK, Paik WK, Kim YB, Lim IK. Methylation of O(6)-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma. Cancer 2001;92: 2760-8.
14. Shi J, Zhang G, Yao D, Liu W, Wang N, Ji M, et al. Prognostic significance of aberrant gene methylation in gastric cancer. Am J Cancer Res 2012;2:116-29.
15. Carvalho B, Pinto M, Cirnes L, Oleiveira C, Machado JC, Suriano G, et al. Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas. Eur J Cancer 2003;39:1222-7.
16. Nan HM, Song YJ, Yun HY, Park JS, Kim H. Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer. World J Gastroenterol 2005;11:3834-41.
17. An C, Choi IS, Yao JC, Worah S, Xie K, Mansfield PF, et al. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin Cancer Res 2005;11:656-63.
18. Lee JH, Park SJ, Abraham SC, Seo JS, Nam JH, Choi C, et al. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene 2004;23:4646-54.
19. Bevilacqua RA, Simpson AJ. Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability. Int J Cancer 2000;87:200-3.
20. Gu M, Kim D, Bae Y, Choi J, Kim S, Song S. Analysis of microsatellite instability, protein expression and methylation status of hMLH1 and hMSH2 genes in gastric carcinomas. Hepatogastroenterology 2009;56:899-904.
21. Sobin L. TNM classification of malignant tumors. 6th ed. New York: Wiley-Blackwell ; 2002.
22. Hamilton SR, Aaltonen LA. WHO classification of tumours pathology and genetics of tumours of digestive system. Lyon: IARC; 2000.
23. Lauren P. The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma. An attempt at a histoloclinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
24. Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH, Kim JS. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol 2003;163:1551-6.
25. Lindsey JC, Lusher ME, Anderton JA, Bailey S, Gilbertson RJ, Pearson AD, et al. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling. Carcinogenesis 2004;25:661-8.
26. Ivanauskas A, Hoffmann J, Jonaitis LV, Markelis R, Juozaityte E, Kupcinskas L, et al. Distinct TPEF/HPP1 gene methylation patters in gastric cancer indicate a field effect in gastric carcinogenesis. Dig Liver Dis 2008;40:920-6.
27. Tang LP, Cho CH, Hui WM, Huang C, Chu KM, Xia HH, et al. An inverse correlation between interleukin-6 and select gene promoter methylation in patients with gastric cancer. Digestion 2006;74:85-90.
28. Ksiaa F, Ziadi S, Amara K, Korbi S, Trimeche M. Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma. Clinica Chimica Acta 2009;404:128-33.
29. Tahara T, Shibata T, Arisawa T, Nakamura M, Yamashita H, Yoshioka D, et al. CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer. Anticancer Res 2010;30:239-44.
30. Ye M, Li D, Zhou F, Guo Q, Xia B. Epigenetic regulation of death-associated protein kinase expression in primary gastric cancers from Chinese patients. Eur J Cancer Prev 2012;21:241-6.
31. Ben Ayed-Guerfali D, Benhaj K, Khabir A, Abid M, Bayrouti MI, Sellami-Boudawara T, et al. Hypermethylation of tumor-related genes in Tunisian patients with gastric carcinoma: clinical and biological significance. J Surg Oncol 2011;103:687-94.
32. Lee KH, Lim SW, Kim HG, Kim DY, Ryu SY, Joo JK, et al. Lack of death receptor 4 (DR4) expression through gene promoter methylation in gastric cancer. Langenbecks Arch Surg 2009;394:661-70.
33. Zhao YF, Zhang YG, Tian XX, Juan D, Zheng J. Aberrant methylation of multiple genes in gastric carcinomas. Int J Surg Pathol 2007;15:242-51.
34. Balassiano K, Lima S, Jenab M, Overvad K, Tjonneland A, Boutron-Ruault MC, et al. Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPICEURGAST). Cancer Lett 2011;311:85-95.
35. Hiraki M, Kitajima Y, Sato S, Mitsuno M, Koga Y, Nakamura J, et al. Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer. Ann Surg Oncol 2010;17:1177-86.
36. Poplawski T, Tomaszewska K, Galicki M, Morawiec Z, Blasiak J. Promoter methylation of cancer-related genes in gastric carcinoma. Exp Oncol 2008;30(2):112-6.
37. Moura Lima E, Ferreira Leal M, Cardoso Smith Mde A, Rodriguez Burbano R, Pimentel de Assumpcao P, Bello MJ, et al. DNA mismatch repair gene methylation in gastric cancer in individuals from northern Brazil. Biocell 2008;32:237-43.
38. Oue N, Sentani K, Yokozaki H, Kitadai Y, Ito R, Yasui W. Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa. Pathobiology 2001;69:143-9.